ENCOPRESIS
MODERATOR: DR. DAPAP
Bingham University Teaching Hospital, Jos.
February 13, 2024
1
2/12/2024
PRESENTERS
2
2/12/2024
S/N | NAME | MATRIC NUMBER |
81 | ODEH, ENE | BHU/17/01/01/0173 |
82 | ODUH, JENNIFER | BHU/17/01/01/0187 |
83 | OGBE, ELIZABETH | BHU/17/01/03/0035 |
84 | OGEDEGBE, FAITH | BHU/17/01/01/0185 |
85 | OGOKE, FAVOUR CHISOM | BHU/17/01/01/0244 |
86 | OGUCHE, WISDOM ONU | BHU/17/01/01/0073 |
87 | OGUNDIJO, USMAN OLAMIDE | BHU/18/01/01/0072 |
90 | OKON-EYO, VICTORIA | BHU/17/01/01/0007 |
OUTLINE
3
2/12/2024
DEFINITION
4
2/12/2024
EPIDEMIOLOGY
5
2/12/2024
AETIOLOGY
Encopresis is considered a non-organic disorder and usually involves a complicated interplay between physiological and psychological factors.
Some of these factors includes;
6
2/12/2024
RISK FACTORS
7
2/12/2024
CLASSIFICATION
8
2/12/2024
Retentive (80-95%): involves
4. Nonretentive or solitary (5-20%): involve
9
2/12/2024
PATHOPHYSIOLOGY
10
2/12/2024
11
2/12/2024
CLINICAL FEATURES
12
2/12/2024
PRIMARY ENCOPRESIS
13
2/12/2024
SECONDARY ENCOPRESIS
14
2/12/2024
DIAGNOSTIC CRITERIA
DSM-V criteria
15
2/12/2024
CLINICAL PRESENTATION
HISTORY
16
2/12/2024
PHYSICAL EXAMINATION
Looking out for
17
2/12/2024
18
2/12/2024
INVESTIGATION
In most patients the diagnosis of encopresis is established on the basis of the history and complete physical examination including a rectal examination.
19
2/12/2024
TREATMENT
NONPHARMACOLOGICAL THERAPY
20
2/12/2024
ACUTE GENERAL TREATMENT
21
2/12/2024
CHRONIC TREATMENT
22
2/12/2024
COMPLICATIONS
23
2/12/2024
PROGNOSIS
24
2/12/2024
PREVENTION
25
2/12/2024
DIFFERENTIAL DIAGNOSIS
26
2/12/2024
CONCLUSION
27
2/12/2024
REFERENCES
28
2/12/2024